Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Fyarro |
|---|---|
| Manufacturer | AadiBioscience, Inc |
| Prescription required | Yes |
Fyarro injectable suspension 1vial x 100mg (sirolimus protein-bound particles for injectable suspension,albumin-bound)
sirolimus protein-bound particles for injectable suspension,albumin-bound
Description
Fyarro injectable suspension 1vial x 100mg (sirolimus protein-bound particles for injectable suspension,albumin-bound) is a medicine catalog record in the MediPriceHub database. Active ingredient: sirolimus protein-bound particles for injectable suspension,albumin-bound. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: AadiBioscience, Inc. Therapeutic category: Medicine Library > Oncology Medicines > Cytoma drugs. Pack information: 100 /, 1. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
FYARRO ® is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).How to Use
Use sirolimus protein-bound particles for injectable suspension,albumin-bound under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: sirolimus protein-bound particles for injectable suspension,albumin-bound. Pack size: 100 /, 1. Pack unit: bottle. Manufacturer: AadiBioscience, Inc. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Cytoma drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Esta información es solo orientativa. Consulta a un profesional sanitario antes de usar cualquier medicamento.